You are here

Novo Nordisk

Can Novo’s blockbuster push on obesity drug semaglutide succeed where others failed?

Endpoints

Thu, 08/10/17 - 11:36 am

Novo Nordisk leans on Victoza as competition increases

BioPharma Dive

Wed, 08/9/17 - 03:09 pm

Novo Nordisk profit flat; upbeat on sales outlook

Marketwatch

Wed, 08/9/17 - 11:15 am

Diabetes drugmakers partner with mobile startups to boost patient engagement

Medical Marketing and Media

Fri, 07/21/17 - 10:03 am

Puma's FDA Decider And Semaglutide's Head-To-Head Battle

Seeking Alpha

Mon, 07/10/17 - 11:09 am

Puma Biotechnology

Novo Nordisk Warns of Possible Cracks in Insulin Devices

RAPS.org

Wed, 07/5/17 - 07:17 pm

Novo Nordisk touts late-stage trial data for Tresiba insulin injection

Drug Delivery Business News

Tue, 07/4/17 - 11:18 pm

clinical trials

Novo Nordisk says obesity drug helps up to 13.8 percent weight loss in phase 2 trial

Reuters

Mon, 06/26/17 - 05:15 pm

What we know from BIO2017

BioPharma Dive

Fri, 06/23/17 - 11:30 am

Seattle Genetics

ImmunoCellular Therapeutics

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

Medical Marketing and Media

Thu, 06/22/17 - 09:32 am

FDA panel supports cardiovascular indication for Novo’s diabetes drug Victoza

Fierce Pharma

Tue, 06/20/17 - 10:53 pm

advisory panels

Novo Nordisk files to add Lantus-matching CV data to Tresiba's European label

Fierce Pharma

Fri, 06/16/17 - 09:35 am

ADA preview: 5 things to watch in diabetes

BioPharma Dive

Sun, 06/11/17 - 09:30 am

Boehringer Ingelheim

PCSK9 inhibitors

Amgen Regeneron

Why Novo Nordisk A/S (ADR) Jumped 10.6% In May

Motley Fool

Sun, 06/11/17 - 09:13 am

Top 10 diabetes drugs by 2016 sales

Fierce Pharma

Thu, 06/8/17 - 10:04 am

AbbVie, Novo Nordisk and Takeda Have the Best Reputations Among Pharma Companies According to Reputation Institute Global Pharma Reptrak® Study

PR Web

Thu, 06/1/17 - 09:19 am

Novo Nordisk seeks to include cardiovascular data in Tresiba insulin label

Drug Delivery Business News

Tue, 05/30/17 - 06:17 pm

AZ's Bydureon cleared a heart safety test, but didn't cut risks. Can it still vie with Novo?

Fierce Pharma

Tue, 05/23/17 - 08:17 am

Novo Nordisk preps Saxenda sales drive in Latin America after its 'phenomenal' Q1

Fierce Pharma

Tue, 05/23/17 - 08:14 am

Nevada bill could force Sanofi, Novo and Lilly to reveal their insulin pricing secrets

Fierce Pharma

Mon, 05/22/17 - 07:48 pm

Pages